Effectiveness and safety of orelabrutinib with rituximab and lenalidomide in low KPS score and elderly patients with newly diagnosed primary central nervous system lymphoma—a single-center retrospective study

被引：0
|
作者：
Xiao-Ling Guo
Zi-Yu Zhao
Xue-Fei Guo
Ya-Bei Zuo
Jin-Ao Li
Zi-Yuan Nie
Jin-Hai Ren
机构：
[1] The Second Hospital of Hebei Medical University,Department of Hematology
来源：
Neurological Sciences | 2024年 / 45卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2931 / 2934
页数：3
相关论文
共 50 条
  • [1] Effectiveness and safety of orelabrutinib with rituximab and lenalidomide in low KPS score and elderly patients with newly diagnosed primary central nervous system lymphoma-a single-center retrospective study
    Guo, Xiao-Ling
    Zhao, Zi-Yu
    Guo, Xue-Fei
    Zuo, Ya-Bei
    Li, Jin-Ao
    Nie, Zi-Yuan
    Ren, Jin-Hai
    NEUROLOGICAL SCIENCES, 2024, 45 (06) : 2931 - 2934
  • [2] Lenalidomide, rituximab, and methotrexate are effective in newly diagnosed primary central nervous system lymphoma
    Yuan, Xianggui
    Xie, Yaping
    Xu, Nengwen
    Liu, Hui
    Chen, Panpan
    Zhao, Aiqi
    Liang, Yun
    Qian, Wenbin
    HAEMATOLOGICA, 2024, 109 (06) : 2005 - 2009
  • [3] Orelabrutinib, rituximab, temozolomide and high-dose methotrexate (RMOT) in newly diagnosed primary central nervous system lymphoma (PCNSL): A retrospective analysis on efficacy and safety.
    Xia, Yi
    Cai, Qingqing
    Zhang, Peng
    Tian, Xiaopeng
    Fang, Xiaojie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Lenalidomide, Rituximab and Methotrexate (R2-MTX) in Newly Diagnosed Primary Central Nervous System Lymphoma
    Yuan, Xianggui
    Liang, Yun
    Liu, Hui
    Xu, Yang
    Zhao, Aiqi
    Xu, Xiaohua
    Qian, Wenbin
    BLOOD, 2021, 138
  • [5] Orelabrutinib, Rituximab, and High-Dose Methotrexate (HD-MTX) in Newly Diagnosed Primary Central Nervous System Lymphoma (PCNSL): A Retrospective Analysis on Efficacy, Safety, and Biomarker
    Zhao, Shihua
    Liu, Yao
    Zhu, Zunmin
    He, Jianxia
    Liu, Lihong
    Wang, Xiaobo
    Zhao, Yuxia
    Hu, Chongling
    Yuan, Xiaoli
    Bai, Sijun
    Geng, Ye
    Huang, Wenrong
    BLOOD, 2022, 140 : 1338 - 1339
  • [6] Rituximab, Methotrexate, Carmustine, Etoposide, and Prednisone (RMBVP) for the treatment of relapsed/refractory primary central nervous system lymphoma: a retrospective single-center study
    Reiss, Samantha N.
    Yerram, Prakirthi
    Modelevsky, Lisa
    Grommes, Christian
    LEUKEMIA & LYMPHOMA, 2022, 63 (03) : 627 - 632
  • [7] Orelabrutinib Combined With Lenalidomide and Immunochemotherapy for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Retrospective Analysis of Case Series
    Yang, Chuanwei
    Cui, Yong
    Ren, Xiaohui
    Li, Ming
    Yu, Kefu
    Shen, Shaoping
    Jiang, Haihui
    Li, Mingxiao
    Zhang, Xiaokang
    Zhao, Xuzhe
    Zhu, Qinghui
    Lin, Song
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [8] Primary central nervous system lymphoma in China: a single-center retrospective analysis of 167 cases
    Xiang-Gui Yuan
    Yu-Rong Huang
    Teng Yu
    Yang Xu
    Yun Liang
    Xiao-Hong Zhang
    Chong-Ran Sun
    Xiao-Ying Zhao
    Annals of Hematology, 2020, 99 : 93 - 104
  • [9] The role of surgical resection in primary central nervous system lymphoma: a single-center retrospective analysis of 70 patients
    Shiqiang Wu
    Junwen Wang
    Weihua Liu
    Feng Hu
    Kai Zhao
    Wei Jiang
    Ting Lei
    Kai Shu
    BMC Neurology, 21
  • [10] The role of surgical resection in primary central nervous system lymphoma: a single-center retrospective analysis of 70 patients
    Wu, Shiqiang
    Wang, Junwen
    Liu, Weihua
    Hu, Feng
    Zhao, Kai
    Jiang, Wei
    Lei, Ting
    Shu, Kai
    BMC NEUROLOGY, 2021, 21 (01)
12345